ONO-2020 / Ono Pharmaceutical - LARVOL DELTA

ONO-2020-02: A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease (clinicaltrials.gov) - P2 | N=240 | Active, not recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Recruiting ➔ Active, not recruiting

Enrollment closed • Alzheimer's Disease • CNS Disorders

ONO-2020-02: A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease (clinicaltrials.gov) - P2 | N=240 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Not yet recruiting ➔ Recruiting

Enrollment open • Alzheimer's Disease • CNS Disorders

A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia (clinicaltrials.gov) - P2 | N=90 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Not yet recruiting ➔ Recruiting

Enrollment open • Alzheimer's Disease • CNS Disorders • Cognitive Disorders • Dementia

A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease (clinicaltrials.gov) - P2 | N=240 | Not yet recruiting | Sponsor: Ono Pharmaceutical Co. Ltd

New P2 trial • Alzheimer's Disease • CNS Disorders

A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia (clinicaltrials.gov) - P2 | N=90 | Not yet recruiting | Sponsor: Ono Pharmaceutical Co. Ltd

New P2 trial • Alzheimer's Disease • CNS Disorders • Cognitive Disorders • Dementia

A Phase 1 Study of ONO-2020 in Healthy Participants (clinicaltrials.gov) - P1 | N=132 | Completed | Sponsor: Ono Pharmaceutical Co. Ltd | Recruiting ➔ Completed

Trial completion

A Phase 1 Study of ONO-2020 in Healthy Participants (clinicaltrials.gov) - P1 | N=138 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Trial completion date: Aug 2023 ➔ Dec 2023 | Trial primary completion date: Aug 2023 ➔ Dec 2023

Trial completion date • Trial primary completion date

A Phase 1 Study of ONO-2020 in Healthy Participants (clinicaltrials.gov) - P1 | N=138 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd

New P1 trial